FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281922010> ?p ?o ?g. }

• W4281922010 abstract "Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): PREFER Introduction With the increased prevalence of chronic diseases, non-healing wounds place a significant burden on the health system, with a prevalence of 2-5%, similar to the one of heart failure. They are persistent full-thickness skin lesions that affect patients suffering from vascular disorders, such as diabetes and peripheral artery disease. Skin implants and substitutes are currently applied to promote the closure of non-healing wounds. However, both approaches are poorly effective because of lack of appropriate vascularization. Purpose To promote the neo-vascularization of non-healing wounds, we use Stromal Vascular Fraction (SVF) as innovative therapeutic opportunity for wound treatment. Here, we aim to 1) characterize and demonstrate the pro-angiogenic role of SVF cells and 2) provide pre-clinical evidence of the therapeutic efficacy of the human SVF in promoting the neo-vascularization in a new mouse model of ischemic, non-healing wound. Methods To assess capacity of SVF-derived cells to improve wound revascularization, we created a new model of non-healing wound generated by wounding an ischemic limb in mice. Human and mouse SVF was purified from adipose tissue and seeded on a clinical-grade skin substitute prior to its implantation on the ischemic wound of a recipient animal. The transplantation of human SVF into NSG immunodeficient mice was verified using species-specific antibodies, while the use of genetically modified mice allowed us to trace the fate of both endothelial and non-endothelial cells upon their transplantation into syngeneic recipient animals. The function of SVF-induced vessels was assessed by systemic injection of biotinylated lectin and by Single Photon Emission Tomography (SPECT) of the treated limb. Results At day 7 the implanted mouse SVF gives rise to a widespread vascular network composed by arteries, capillaries, veins, as well as lymphatic vessels. Similarly, human SVF-derived endothelial cells formed hybrid human-mouse vessels that were stabilized by perivascular cells. At both histological and functional analysis, these vessels were connected with the host circulatory system and determined a 2-fold increase in tissue perfusion. The comparison of the activity of human SVF from different donors allowed us to disclose its dual mechanisms of action. Conclusions Here we demonstrated the efficacy of the SVF in promoting neo-vascularization of a skin substitute in a mouse model of ischemic, non-healing wounds. Its therapeutic efficacy relies on dual mechanisms of action. On the one hand, SVF-derived ECs engraft and expand, directly forming new vascular units that colonize the scaffold and extend into surrounding tissues. On the other hand, the mesenchymal progenitors stimulate the expansion of the host vasculature, which extends into the scaffold, with the eventual appearance of donor-host hybrid vessels. Collectively, these data support the use of human SVF as a powerful cell therapy to treat non-healing wounds." @default.
• W4281922010 created "2022-06-13" @default.
• W4281922010 creator A5002353308 @default.
• W4281922010 creator A5011847088 @default.
• W4281922010 creator A5022450686 @default.
• W4281922010 creator A5030764152 @default.
• W4281922010 creator A5040481269 @default.
• W4281922010 creator A5043540285 @default.
• W4281922010 creator A5046467955 @default.
• W4281922010 creator A5046695297 @default.
• W4281922010 creator A5049883384 @default.
• W4281922010 creator A5064915710 @default.
• W4281922010 creator A5072943766 @default.
• W4281922010 creator A5076278835 @default.
• W4281922010 creator A5076644985 @default.
• W4281922010 creator A5081943943 @default.
• W4281922010 creator A5086826541 @default.
• W4281922010 date "2022-06-01" @default.
• W4281922010 modified "2023-09-24" @default.
• W4281922010 title "Effective revascularization of non-healing wounds by the human Stromal Vascular Fraction relies on direct cell integration and paracrine signals" @default.
• W4281922010 doi "https://doi.org/10.1093/cvr/cvac066.239" @default.
• W4281922010 hasPublicationYear "2022" @default.
• W4281922010 type Work @default.
• W4281922010 citedByCount "0" @default.
• W4281922010 crossrefType "journal-article" @default.
• W4281922010 hasAuthorship W4281922010A5002353308 @default.
• W4281922010 hasAuthorship W4281922010A5011847088 @default.
• W4281922010 hasAuthorship W4281922010A5022450686 @default.
• W4281922010 hasAuthorship W4281922010A5030764152 @default.
• W4281922010 hasAuthorship W4281922010A5040481269 @default.
• W4281922010 hasAuthorship W4281922010A5043540285 @default.
• W4281922010 hasAuthorship W4281922010A5046467955 @default.
• W4281922010 hasAuthorship W4281922010A5046695297 @default.
• W4281922010 hasAuthorship W4281922010A5049883384 @default.
• W4281922010 hasAuthorship W4281922010A5064915710 @default.
• W4281922010 hasAuthorship W4281922010A5072943766 @default.
• W4281922010 hasAuthorship W4281922010A5076278835 @default.
• W4281922010 hasAuthorship W4281922010A5076644985 @default.
• W4281922010 hasAuthorship W4281922010A5081943943 @default.
• W4281922010 hasAuthorship W4281922010A5086826541 @default.
• W4281922010 hasConcept C126322002 @default.
• W4281922010 hasConcept C141071460 @default.
• W4281922010 hasConcept C142724271 @default.
• W4281922010 hasConcept C16930146 @default.
• W4281922010 hasConcept C170493617 @default.
• W4281922010 hasConcept C171056886 @default.
• W4281922010 hasConcept C171089720 @default.
• W4281922010 hasConcept C2779464278 @default.
• W4281922010 hasConcept C2780269544 @default.
• W4281922010 hasConcept C2780394083 @default.
• W4281922010 hasConcept C2780745355 @default.
• W4281922010 hasConcept C2911091166 @default.
• W4281922010 hasConcept C500558357 @default.
• W4281922010 hasConcept C502942594 @default.
• W4281922010 hasConcept C71924100 @default.
• W4281922010 hasConcept C7876069 @default.
• W4281922010 hasConcept C86803240 @default.
• W4281922010 hasConcept C95444343 @default.
• W4281922010 hasConceptScore W4281922010C126322002 @default.
• W4281922010 hasConceptScore W4281922010C141071460 @default.
• W4281922010 hasConceptScore W4281922010C142724271 @default.
• W4281922010 hasConceptScore W4281922010C16930146 @default.
• W4281922010 hasConceptScore W4281922010C170493617 @default.
• W4281922010 hasConceptScore W4281922010C171056886 @default.
• W4281922010 hasConceptScore W4281922010C171089720 @default.
• W4281922010 hasConceptScore W4281922010C2779464278 @default.
• W4281922010 hasConceptScore W4281922010C2780269544 @default.
• W4281922010 hasConceptScore W4281922010C2780394083 @default.
• W4281922010 hasConceptScore W4281922010C2780745355 @default.
• W4281922010 hasConceptScore W4281922010C2911091166 @default.
• W4281922010 hasConceptScore W4281922010C500558357 @default.
• W4281922010 hasConceptScore W4281922010C502942594 @default.
• W4281922010 hasConceptScore W4281922010C71924100 @default.
• W4281922010 hasConceptScore W4281922010C7876069 @default.
• W4281922010 hasConceptScore W4281922010C86803240 @default.
• W4281922010 hasConceptScore W4281922010C95444343 @default.
• W4281922010 hasIssue "Supplement_1" @default.
• W4281922010 hasLocation W42819220101 @default.
• W4281922010 hasOpenAccess W4281922010 @default.
• W4281922010 hasPrimaryLocation W42819220101 @default.
• W4281922010 hasRelatedWork W2038099377 @default.
• W4281922010 hasRelatedWork W2052774003 @default.
• W4281922010 hasRelatedWork W2378339207 @default.
• W4281922010 hasRelatedWork W2433347143 @default.
• W4281922010 hasRelatedWork W2548382503 @default.
• W4281922010 hasRelatedWork W2886093265 @default.
• W4281922010 hasRelatedWork W3115604897 @default.
• W4281922010 hasRelatedWork W329978672 @default.
• W4281922010 hasRelatedWork W4200570913 @default.
• W4281922010 hasRelatedWork W4225896686 @default.
• W4281922010 hasVolume "118" @default.
• W4281922010 isParatext "false" @default.
• W4281922010 isRetracted "false" @default.
• W4281922010 workType "article" @default.